Swedencare shares moved up about 2% after the company presented its outlook at a capital markets day where management reiterated a financial framework focused on sustained, double-digit organic growth and mid-term operating EBITDA margins in excess of 26%.
Management also reaffirmed a leverage ceiling of below 2x and offered additional detail about the drivers behind those targets. The company described its operating environment as one supported by the humanization and premiumization of pet care, alongside a trend toward preventive treatments. These secular forces underpin its assumption of high-single-digit market growth, management said, driven by rising spend per pet and continued online penetration.
Executives highlighted a multi-channel growth approach. That strategy includes sales through online marketplaces such as Amazon and Chewy, a direct-to-consumer channel, expansion in Big Box retail, and activities in pharmaceutical production. The company identified its pharmaceutical and contract development and manufacturing organization, or CDMO, business as a strategic focus because it offers the potential for higher growth, contracted volumes and stronger margins.
However, management acknowledged uncertainty about the speed and magnitude with which the CDMO segment will change the companys overall business mix. They outlined a path to the stated margin goals that combines gross margin expansion with operating expense scalability, and said the margin improvement profile is tilted toward the later stages of the forecast period.
Those timing dynamics reflect, management said, a normalization after periods of elevated cost related to Amazon transitions, the rollout into retail channels, and an ERP implementation, plus the scaling effect of higher-margin pharmaceutical production. Jefferies commented: "The CMD reinforces the integrity of the longterm model, but confirms that the investment case is now execution-led."
The stock has underperformed year-to-date, with market attention shifting from the long-term structural potential of the business model to managements ability to execute simultaneously across multiple operational initiatives.
Contextual note: The companys targets, channel mix and the role of the CDMO segment were presented by management at the capital markets day. The timing and extent to which CDMO will affect the business mix were described as uncertain.